Universal access to antiretroviral therapy: When, not if

被引:4
作者
Carpenter, CCJ [1 ]
机构
[1] Brown Univ, Miriam Hosp, Dept Med, Providence, RI 02906 USA
关键词
D O I
10.1086/499062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:260 / 261
页数:2
相关论文
共 8 条
[1]  
CURRAN J, 2004, SCALING TREATMENT GL
[2]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[3]   No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa [J].
Gill, CJ ;
Hamer, DH ;
Simon, JL ;
Thea, DA ;
Sabin, LL .
AIDS, 2005, 19 (12) :1243-1249
[4]   The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India [J].
Kumarasamy, N ;
Solomon, S ;
Chaguturu, SK ;
Mahajan, AP ;
Flanigan, TP ;
Balakrishnan, P ;
Mayer, KH .
AIDS, 2003, 17 (15) :2267-2269
[5]  
LEE JW, 2005, PROGR GLOBAL ACCESS
[6]   Adherence is not a barrier to successful antiretroviral therapy in South Africa [J].
Orrell, C ;
Bangsberg, DR ;
Badri, M ;
Wood, R .
AIDS, 2003, 17 (09) :1369-1375
[7]   Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda [J].
Spacek, LA ;
Shihab, HM ;
Kamya, MR ;
Mwesigire, D ;
Ronald, A ;
Mayanja, H ;
Moore, RD ;
Bates, M ;
Quinn, TC .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (02) :252-259
[8]   Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 X 109 cells/L [J].
Wood, E ;
Hogg, RS ;
Yip, B ;
Harrigan, PR ;
O'Shaughnessy, MV ;
Montaner, JSG .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :810-816